Navigation Links
Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
Date:8/28/2007

e clinical development costs, U.S. commercialization costs and U.S. profits equally. Novartis will be responsible for commercialization in the rest of the world and will pay HGS a royalty on those sales. Clinical development, commercial milestone and other payments to HGS could total as much as $507.5 million, including $92.5 million received to date and the $40 million payment expected in September 2007.

About Albuferon

Albuferon is a novel long-acting form of interferon alpha created by HGS using its proprietary albumin fusion technology. Albuferon results from the genetic fusion of human albumin and interferon alpha. Human albumin is the most prevalent naturally occurring blood protein in the human circulatory system, persisting in circulation in the body for more than 20 days. Research shows that genetic fusion of therapeutic proteins to human albumin decreases clearance and prolongs the half-life of the proteins. Recombinant interferon alpha is approved for the treatment of hepatitis C, hepatitis B and a number of cancers.

About Hepatitis C

Hepatitis C is an inflammation of the liver caused by the hepatitis C virus. An estimated 170 million people worldwide are infected with the virus, including nearly 4 million people in the United States. When detectable levels of the hepatitis C virus persist in the blood for at least six months, a person is diagnosed as having chronic hepatitis C. The hepatitis C virus can cause serious liver disease in a significant proportion of people who are infected, leading to cirrhosis, primary liver cancer and even death.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercializati
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 As ... MeMD, Inc proudly announces the release of their ... and Fitness ". , MeMD's goal was to ... landscape of Health 2.0, Health 3.0 and mHealth.The ... likely transform medical care and the fitness industry ...
(Date:6/18/2013)... Minneapolis, MN (PRWEB) June 18, 2013 ... the Saniclave 200 prevent the dangers of ... confusing features, like knobs, analog pressure gauges, hot surfaces ... older autoclave, or a new, modern autoclave, Revolutionary Science ... use fresh water. Older autoclave designs will recycle ...
(Date:6/18/2013)... On June 11, 2013 the Centers for Medicare ... memorandum concluding that FDG Position Emission Tomography (PET) is ... strategy, and the agency ended the requirement for ... was developed jointly by the ACR and WMIS as ... Evidence Development (CED) program to determine if FDG-PET scans ...
(Date:6/17/2013)... FRANCISCO , June 17, 2013  KaloBios Pharmaceuticals, ... appointment of Donald R. Joseph as Chief ... years of biopharmaceutical industry experience and has worked in ... global health non-profit organizations. (Logo: ... successful track record as a general counsel and senior ...
Breaking Biology Technology:MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4
... CLAREMONT, Calif., Oct. 25, 2011 Keck Graduate Institute (KGI) ... speaker at the upcoming Pichia 2012 conference from February 23 ... spent years conducting internationally-renowned research on the development and use ... system for the production of recombinant proteins. At ...
... JUNCTION, N.J., Oct. 25, 2011 Insmed Incorporated (Nasdaq CM: ... Tuesday, November 8 th , 2011, at 8:30 AM ET, ... 2011.  Insmed intends to issue its quarterly financial results press ... To participate in the live conference call, ...
... Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the ... on operations and disclosed the outcome of a strategic ... management and AMT,s Board of Directors that enables the ... development. The CHMP,s recent opinion, while not approving Glybera®, ...
Cached Biology Technology:KGI Professor Cregg to Be Featured Speaker at Pichia 2012 Conference 2Insmed to Host 2011 Third Quarter Earnings Conference Call 2Insmed to Host 2011 Third Quarter Earnings Conference Call 3Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 2Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 3Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 4
(Date:6/17/2013)... Biochemical and Biophysical Research Communications , Saint Louis ... previously unknown viruses. The technique offers the potential to ... identified a particular virus as the likely source of ... scientists use blood serum as a biological source to ... complete deciphering of the human genome, SLU researchers used ...
(Date:6/17/2013)... bacteria, and algae, is a common component of sugar-free ... the medical field it,s approved by the FDA ... used during surgery as a substance that opens the ... , Now Profs. Ehud Gazit and Daniel Segal of ... and the Sagol School of Neuroscience, along with their ...
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
Breaking Biology News(10 mins):Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Artificial sweetener a potential treatment for Parkinson's disease 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... International Scientific Congress attended by more than 2,500 delegates ... The conclusions will be published as a full report ... the Danish Prime Minister Mr. Anders Fogh Rasmussen today. ... Conference in December 2009 and will hand over the ...
... have taken a first look at the broad genetic ... Although scientists have known for more than a century ... are likely to suffer from low reproductive success, the ... still the subject of debate. The new study, ...
... An international research team, involving Professor Rajeev Ahuja at ... to understand the mechanism behind the catalytic effects of ... a synergistic approach and the results, published this week ... Letters , will fasten efforts to develop new catalysts. ...
Cached Biology News:'Climate change: Global risks, challenges and decisions' 2'Climate change: Global risks, challenges and decisions' 3Researchers take first look at the genetic dynamics of inbreeding depression 2Researchers take first look at the genetic dynamics of inbreeding depression 3Revealing new applications for carbon nanomaterials in hydrogen storage 2
... the professional, student, or faculty researcher, the new ... your research and improve the quality of your ... the edge that researchers using LI-COR DNA analysis ... The 4300 System is a third generation instrument ...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... testing at various temperatures, this chamber ... a clean heating unit to maintain ... 140F. Transparent panels allow full visibility, ... access to the work area. Includes ...
... Label IT siRNA Tracker Intracellular Localization ... a straight forward approach to directly ... design, in an efficient yet non-destructive ... Subcellular localization and functional inhibition of ...
Biology Products: